Related Experiment Videos
Continuous vasopressin replacement in diabetes insipidus
Archives of Disease in Childhood
|August 1, 1990
Insights
Severe brain injury can cause diabetes insipidus in children. Continuous intravenous vasopressin and fluid replacement safely and effectively corrected polyuria and electrolyte imbalances in five pediatric patients.
Area of Science:
- Pediatric Endocrinology
- Nephrology
- Critical Care Medicine
Background:
- Severe brain injury is a known cause of central diabetes insipidus.
- Diabetes insipidus in children presents with polyuria, hypernatremia, and dilute urine.
- Management of pediatric diabetes insipidus requires careful fluid and hormone replacement.
Purpose of the Study:
- To evaluate the efficacy and safety of continuous intravenous vasopressin combined with crystalloid replacement in children with diabetes insipidus secondary to severe brain injury.
Main Methods:
- Five pediatric patients with diabetes insipidus post-brain injury were treated.
- Continuous intravenous infusion of aqueous vasopressin was administered.
- Appropriate crystalloid solutions were used for fluid and electrolyte replacement.
Main Results:
- All five patients showed safe and effective correction of polyuria.
- Hypernatremia and decreased urine osmolality were resolved in all participants.
- Treatment success was achieved within 8 to 28 hours.
Conclusions:
- Continuous intravenous vasopressin and crystalloid replacement is a safe and effective treatment for pediatric diabetes insipidus.
- This therapeutic approach rapidly normalizes fluid and electrolyte balance in affected children.
- Prompt management is crucial for children with severe brain injury and subsequent diabetes insipidus.
Abstract:
Five children who developed diabetes insipidus as a manifestation of severe brain injury received continuous intravenous treatment with a solution containing both aqueous vasopressin and appropriate crystalloid replacement. Polyuria, hypernatraemia, and decreased urine osmolalities were safely corrected in all patients within eight to 28 hours.